Live Analytics
Comments 0
Omicron growth in Norway Analytics Table
Income Estimates for Omicron growth in Norway
Based on this YouTube video's total view count of 618K views and industry-standard rates, the estimated total earning is $433 - $1.23K through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Omicron growth in Norway
Explore Omicron growth in Norway with 618,425 views, 19,128 likes, and 4,636 comments. Experience the impact of this video content that has captured audience attention.
Link to free download of my 2 textbooks http://159.69.48.3/ Louise Restaurant and Bar, night of 26th November https://www.telegraph.co.uk/world-news/2021/12/07/europes-biggest-omicron-outbreak-appears-mild-say-norway-covid/ Oslo, Norway, Christmas party Scatec solar power company One or two returned traveller Had returned days earlier 120 people (all double vaccinated) Mingled with outside groups later 70 of the 120 plus 50 others tested positive Half tested positive for omicron 13 proven in sequencing Dr. Tine Ravlo, Oslo, infectious diseases They have symptoms like fever, cough, headache, muscle pain, fatigue, but for now none of them have become severely ill and none of them have been treated in hospital The next day, one of two employees, recently returned from South Africa tested positive Norway's state epidemiologist, Frode Forland Sheer number of people infected at a single event, omicron considerably more infectious than delta Prof Forland, Norwegian Institute of Public Health One of three scenarios for omicron, it would be both very mild and very transmissible That is the hope That is the best scenario we can have That it's getting minder, most people will get it, and they will get a natural immunity It might be that it has now replicated and mutated so many times, that this is the optimal position from the virus' point of view, to spread widely and not kill the hosts That's what we've seen with other diseases beforehand. And of course, then it gets into more like an endemic phase Now this is not the end Nor is it the end of the beginning Rather it is the beginning of the end Sally I've had Delta, this time last year (pretty rough, took 6 months to fully recover) and I have Omicron now. The symptoms of Omicron are as you state. I am vaccinated. Helgard Living in SA (Gauteng) and have tested (+) 2 days ago, The symptoms is 100% correct as stated. Also after 1st symptoms, 3 days after i don't even know that i was sick. Body and muscle aches and pains Headache Tiredness (1 to 2 days) Slight sore throat No severe cough No runny nose Graph refs https://ourworldindata.org/coronavirus SA. Live data, hospital patients who have tested positive https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ South Africa references https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/sars-cov-2-genomic-surveillance-update/ Weekly deaths in SA https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa Variants in SA https://www.worldometers.info/coronavirus/country/south-africa/ Sir Patrick Vallance from pandemic to endemic where this becomes a more regular infection like flu over time This virus has mutated a lot, quickly and that is sort of what you would expect at this stage the good news is that, so far, it looks as though when you get very high antibody levels with the booster vaccine it's definitely having some effect against it in the laboratory studies Boris Johnson Work-from-home from Monday Facemasks will be enforced in public venues Covid passes mandatory for nightclubs Daily testing instead of isolation for omicron contacts First plant-based coronavirus vaccine CoVLP (20 years of R and D) https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-announce-positive-phase-3-efficacy-and-safety-results/ GlaxoSmithKline and Medicago Primary endpoints and secondary endpoints met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3% efficacy against COVID-19 of any severity caused by Delta variant Vaccine candidate was well-tolerated, with no related serious adverse events reported in the vaccine group 24,000 adults across six countries Phase 3 placebo-controlled efficacy study Canada Medicago’s plant based vaccine British GSK’s pandemic adjuvant Brian Ward, medical officer at Medicago plants that are used simply act as bioreactors to produce the antigen Health Canada U.S. Food and Drug Administration UK, Medicines and Healthcare products Regulatory Agency World Health Organization WHO Produced cheaply in very high amounts Carrier plants such as potatoes and corn Antigens created are fridge stable and can be stored for long periods of time the likelihood that contamination by a plant virus would have an adverse effect on humans is almost negligible Virus-Like Particles for protein vaccines Creating empty shells, no RNA Sally Can you explain how one variant replaces the other? Does the other variant just fade out? Campbell's Pathophysiology Notes, Amazon orders for the UK, https://www.amazon.co.uk/dp/B012HWC8SU/ref=cm_sw_em_r_mt_dp_AYC5Q7G3H2B3T4BCHQY0 Campbell's Physiology Notes https://www.amazon.co.uk/dp/0955379725/ref=cm_sw_em_r_mt_dp_K0MXMAP26Y77TY4J90FB
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

